Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The Protocol Gap Between Clinical Data and Reddit Reality Clinical studies from Metabolic Pharmaceuticals established AOD-9604 as a modified fragment of human growth hormone (positions 176-191) with selective lipolytic activity
follow sterile compounding guidelines Injection site: Abdomen subcutaneous, rotating sites each injection Stacking: Often evaluated in combination with CJC-1295/Ipamorelin for complementary anabolic-lipolytic effects, or with BPC-157 for tissue repair support These parameters reflect research protocols and published clinical trial data
The research results, however, are mixed and include: A 2018 review of 20 randomized controlled trials looked at ALA use in people with metabolic disorders, including type 2 diabetes
If you want more energy or deeper detox support, we are here to help you reach your wellness goals.To book an appointment for IV therapy at our wellness center in Madison, AL, call (256) 325-0955 or visit us at 1230 Slaughter Rd Suite C, Madison, AL.
